Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.
Multi-day accumulation Oct 20–22: 45,676 shares at $13.24, 438,900 shares at $13.12, 163,780 shares at $13.39. Weighted avg ~$13.19. Czech value/activist fund adding aggressively. Current price $13.52, +2.5% vs avg buy.
Purchased Oct 20 at $35.01 weighted avg (range $34.51–$35.34). Rule 10b5-1 plan adopted Aug 7, 2026 — scheduled, non-discretionary buy. Nippon Life holds 130M+ shares post-transaction. Current price $35.59, +1.7% vs buy.
Purchased Oct 21 at $20.42. Saba CEF activism cluster — 5 Form 4s filed Oct 22 across various closed-end funds. MXF trades at discount to NAV; Saba likely seeking tender offer or board representation. Current price $20.18, -1.2% vs buy.
Purchased Oct 21 at $5.73. Part of Saba Capital's same-day CEF discount activism cluster. LEO is a muni bond CEF; Saba holds 6.48M shares post-transaction. Current price $5.70, -0.5% vs buy.
AIThe day in insider buying
SEC Form 4 Insider Scan — October 23, 2026
Scanned the last 24 hours of EDGAR Form 4 filings (Oct 22–23, 2026). 4 qualifying buys (≥ $250K, transaction type P) totalling $15.9M.
Headline Filings
DOLE — Pale Fire Capital SE / Dusan Senkypl (10% Owner) bought 648,356 shares ≈ $8.55M at $13.19 avg over 3 consecutive days (Oct 20–22); now $13.52 (+2.5% since buy). Czech activist/value fund aggressively accumulating Dole plc. (filing)
CRBG — Nippon Life Insurance Co (10% Owner) bought 193,357 shares ≈ $6.77M at $35.01 avg (Oct 20); now $35.59 (+1.7% since buy). Largest Japanese life insurer continuing its systematic accumulation under a Rule 10b5-1 plan adopted Aug 7, 2026. (filing)
MXF — Saba Capital Management LP / Boaz Weinstein (10% Owner) bought 16,035 shares ≈ $327K at $20.42 (Oct 21); now $20.18 (−1.2% since buy). (filing)
LEO — Saba Capital Management LP / Boaz Weinstein (10% Owner) bought 45,831 shares ≈ $263K at $5.73 (Oct 21); now $5.70 (−0.5% since buy). (filing)
Notes
Themes: Today's qualifying activity was dominated by large institutional 10%+ owners rather than classic C-suite insiders. No CEO/CFO/Director open-market purchases crossed the $250K threshold, which is notable. The session breaks into two clusters:
Cross-border accumulation: Pale Fire Capital (Prague-based; led by Dusan Senkypl, who also chairs the firm's SICAV) bought nearly 650K shares of DOLE across three sessions, spending ~$8.55M. The multi-day cadence and weighted-average prices ($13.12–$13.39) suggest a deliberate accumulation campaign, not a one-off trade. Dole plc is a value-play at ~5× EV/EBITDA. Nippon Life's CRBG add is a continuation of a 10b5-1 program; Nippon has been a cornerstone shareholder since Corebridge's 2022 AIG spin-off.
CEF discount activism (Saba Capital): Boaz Weinstein's Saba Capital filed 5 Form 4s on Oct 22 for various closed-end funds—only MXF ($327K) and LEO ($263K) cleared the $250K bar. The other three (DSM at $109K, GF at $26K, ECF at $30K) were sub-threshold. Saba's strategy: buy CEFs trading at significant NAV discounts and push for open-ending, tender offers, or board seats. Both MXF and LEO trade at persistent discounts to NAV.
Notable near-miss: John Maraganore (Director, Rapport Therapeutics / RAPP) bought 9,411 shares at $26.45 avg = ~$249K on Oct 22 — just below the $250K threshold. Multiple RAPP directors bought the same day, suggesting cluster conviction following RAPP's recent clinical data; total cluster value was ~$450K across 4 filers.
Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.
SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's
stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what
average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free,
and a new scan is posted every trading day. How to read insider buying →
See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.